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Effect of furosemide on renal autoregulation. The effect of
furosemide administration on renal blood flow (RBF) and glomeru-
lar filtration rate (GFR) autoregulation was examined in pentobar-
bital-anesthetized dogs during unilateral renal artery constriction,
which reduced renal perfusion pressure (RPP) in 20 mm Hg decre-
ments from 140 to 40 mm Hg. In the first group of animals, at RPP
above 80 mm Hg, RBF autoregulation was absent 15 mm after
initiating furosemide infusion (5 mg/kg of body wt, prime; and 5
mg/kg/hr), as changes in RPP were accompanied by proportional
changes in RBF. At both 120 and 140 mm Hg, RBF was signifi-
cantly greater than control (3.96 0.4 mI/ming) and averaged
5.20 0.6 and 6.10 0.7 mllmmng, respectively. After 60 mm of
continuous furosemide infusion, however, autoregulatory ability
as well as RBF returned to control values. GFR, estimated from
inulin extraction and renal blood plasma flow, autoregulated dur-
ing control and at both 15 and 60 mm. To test the hypothesis that
prostaglandins (PG) may mediate the early vasodilatation
observed during furosemide infusion, a second series of experi-
ments were performed in which animals were pretreated with
either indomethacin (10 mg/kg) or RO 20-5720(2mg/kg). Forty-five
minutes following adminstration of either PG synthesis inhibitor,
RBF autoregulation was still demonstrable; overall RBF, how-
ever, decreased (P <0.01) from 3.9 0.2 to 2.6 0.2 mllming at
any RPP between 140 and 100 mm Hg. Fifteen minutes after
furosemide infusion, RBF autoregulatory capability was again
abolished, and RBF rose from 2.6 0.2 to 4.0 0.5 and to 3.6
0.4 mI/ming (each, P < 0.01) at RPP of 140 and 120 mm Hg,
respectively. Summary. This study has demonstrated that the
excellent RBF autoregulatory capability of dogs can be abolished
early after furosemide administration; this acute diuretic-related
abolishment of vascular responsiveness is reversed within 60 mm.
PG's do not appear to be directly involved in normal autoregulato-
ry response nor in inducing renal vasodilatation following furosem-
ide. Finally, GFR autoregulation is well maintained during furo-
semide administration. The mechanism for the early loss of renal
autoregulatory ability remains obscure. Changes in ECF volume,
renin secretory rate, or plasma furosemide concentrations do not
appear to be directly responsible.
Effet du furosémide stir l'autoregulation rénale. L'effet du furo-
sémide sur l'autorégulation du debit sanguin renal (RBF) et du
debit de filtration glomérulaire (GFR) a été étudié, chez des chiens
anesthésiés par le pentobarbital, au cours d'une constriction uni-
latérale de l'artère rénale qui a réduit la pression de perfusion
rénale (RPP) de 140 a 40 mm Hg par décréments de 20 mm Hg.
Dans le premier group d'animaux, a une RPP supérieure a 80 mm
Hg, l'autoregulation de RBF ne s'exerce plus 15 mm après le debut
de Ia perfusion de furosémide (dose initiale, 5 mg/kg; et dose
d'entretien, 5 mg'kg/hr), puisque les modifications de RPP sont
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accompagnées par des modifications proportionnelles de RBF. A
120 et 140 mm Hg de RPP, RBF est significativement supérieur
aux valeurs contrôles (3,96 0,4mI/mm g) les valeurs moyennes
sont 5,20 0,6 et 6,10 0,7 mI/mm g respectivement. Soixante
minutes après le debut de Ia perfusion de furosémide, cependant,
La capacité d'autoregulation et RBF reviennent aux valeurs con-
trôles. Le GFR, calculé a partir de l'extraction de la créatinine et
du debit plasmatique renal, est autorégulé au cours de Ia période
contrOle et aussi bien a 15 qu'à 60 mm. Pour étudier l'hypothèse
selon laquelle les prostaglandines (PG) peuvent être le médiateur
de Ia vasodilatation précoce observée au cours de l'administration
de furosémide, une seconde série d'expériences a été réalisée au
cours de laquelle les animaux ont préalablement été traités soit par
l'indométhacine (10 mg/kg) ou RO 20-5720 (2 mg/kg). Quarante
cinq minutes après l'administration de l'un ou l'autre inhibiteur de
Ia synthese de PG l'autoregulation est encore observée mais le
RBF global est diminué (P < 0,01) de 3,9 0,2 a 2,6 0,2 ml/
min.g a n'importe quel RPP entre 140 et 100 mm Hg. Quinze
minutes après le furosémide Ia capacité d'autorégulation de RBF
est a nouveau abolie et RBF augmente de 2,6 0,2a 4,0 0,5 et a
3,6 0,4 mJlming(P <0,01 dansles deux cas) aux RPPde l4Oet
120 mm Hg respectivement. En conclusion ce travail démontre
que l'excellente capacité d'autoregulation de RBF chez le chien
peut être abolie précocément après l'administration de furosé-
mide. Cette abolition aiguë et liée au diuretique de Ia réponse
vasculaire disparait en 60 mm. Les PG ne semblent être directe-
ment impliquCes ni dans La réponse autoregulatrice normale ni
dans Ia genèse de Ia vasodilatation consecutive a la furosémide.
Enfin, l'autoregulation de GFR est bien maintenue au cours de
l'administration de furosémide. Le mécanisme de Ia disparition
transitoire de l'autoregulation demeure obscur. Ni les moclifica-
tions du volume extracellulaire nile debit de sécrétion de refine, ni
Ia concentration plasmatique de furosémide ne paraissent être
directement responsables.
It has been demonstrated that a variety of vaso-
dilators, when infused into the renal artery in dogs,
have the ability to reduce the autoregulatory capabil-
ity of renal blood flow (RBF); during administration
of these agents, RBF changes more or less in direct
proportion to changes in renal perfusion pressure
(RPP) [1, 21. Studies, however, with loop-acting
diuretics, which can also increase RBF when admin-
istered systemically, have shown conflicting results.
For example, Kiil, Kjekshus, and Loyning [3] found
that the i.v. administration of ethacrynic acid abol-
ished the autoregulation of RBF. Yet, more recently,
Kiil [4] reported that ethacrynic acid did not affect
the kidney's ability to autoregulate blood flow. In an
independent study, Brody et al [5] found that etha-
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crynic acid inhibited autoregulation of RBF, while
furosemide was able to impair autoregulation in
some experiments but not in others. With these
apparently conflicting results as to the efficacy of
ethacrynic acid and furosemide in altering RBF auto-
regulatory capability, we decided to reexamine the
influence of furosemide on the autoregulation of RBF
at various time intervals and renal perfusion pres-
sures during administration of this potent loop
diuretic. In addition, autoregulation of glomerular
filtration rate (GFR), estimated from inulin extrac-
tion, was examined before and during furosemide
infusion.
Because the renin-angiotensin system can modu-
late the level of renal vascular resistance (RVR),
measurements of plasma renin activity (PRA) and
renin secretion rate (RSR) were performed just prior
to performing each autoregulation curve during con-
trol and again at 15 and at 60 mm following furosem-
ide administration [6, 71.
The results of these experiments suggest that early
after its administration, furosemide severely upsets
RBF autoregulation; however, autoregulation of
RBF returns after one hour of continuous furosemide
infusion. In addition, GFR continued to exhibit
excellent autoregulatory capability throughout furo-
semide administration.
In an attempt to explore the mechanism by which
furosemide altered the autoregulatory capability of
RBF, we examined the potential role of prostaglan-
dins (PG) in mediating this response. It has been
demonstrated that furosemide increases renal PG-E2
secretion [8] and that intrarenal infusion of PG-E2
abolishes RBF autoregulation [1]. Therefore, in
another series of experiments, the effect on RBF
autoregulation was reexamined during inhibition of
PG synthesis. Impairment of RBF autoregulation
was still observed during furosemide infusion at 15
mm in the absence of PG.
Methods
Twenty dogs of either sex, weighing 20.1 1.0 kg
(mean SEM; range, 15 to 25 kg), were anesthetized
with sodium pentobarbital i.v. (25 to 30 mg/kg of
body wt) and intubated with an endotracheal tube.
Supplemental pentobarbital anesthesia was adminis-
tered throughout the experiment to maintain a stable
level of light anesthesia. Polyethylene catheters were
inserted in an external jugular and femoral veins for
infusion of clearance solutions and drugs. During
surgery, hypotonic (0.45%) saline was infused at 2
ml/min, followed by a continuous infusion of isotonic
(0.9%) saline at 4 mllmin until completion of the
control period. Inulin in 0.9% saline was infused at
1.0 ml/min via a femoral vein catheter to maintain
plasma levels at approximately 100 mgldl. The left
femoral artery was catheterized to collect arterial
blood samples and to monitor systemic arterial pres-
sure with a pressure transducer (model 377, Harvard
Apparatus Co., Inc.). The right ureter was visualized
via a suprapubic incision and cannulated with poiy-
ethylene tubing for urine collection.
The left kidney was approached through a subcos-
tal retroperitoneal incision, and the renal artery, vein
and ureter were carefully separated. An electromag-
netic flow probe (Carolina Medical Electronics, Inc.)
was placed on the exposed renal artery near the aorta
to continuously measure RBF. Distal to the probe, a
curved 23-gauge needle which was connected to a
second Harvard pressure transducer was inserted
into the renal artery against the direction of blood
flow to continuously monitor RPP. This needle was
kept patent by an infusion of heparinized saline at 0.2
ml/min with a Harvard infusion pump. Calibration of
this transducer was performed during this slow infu-
sion. An adjustable plastic clamp was placed
between the needle and flow probe to alter unilateral
RPP. In addition, a catheter was placed in the renal
vein via the left gonadal vein to collect renal venous
blood. Finally, the left ureter was cannulated near
the renal hilus.
Effect offurosemide on RBF and GFR autoregu-
lation (group 1, N = 10). Each experiment was
divided into a control and experimental period. Dur-
ing the control period, initiated 60 mm after begin-
ning the inulin infusion, the autoregulatory capability
of the left kidney was examined by constricting the
renal artery with the plastic clamp. RBF autoregula-
tion was monitored witha flow meter (Carolina Med-
ical Electronics, Inc.) coupled to a recorder (Bio-
graph ®, Harvard Apparatus, Inc.). By tightening the
clamp, RPP was reduced in 20-mm Hg decrements
from 140 mm Hg; and RBF was examined at a total
of approximately six different pressures, both above
and below the lowest RPP limit of autoregulation.
Thus, a distinct RBF vs. RPP relationship was deter-
mined for each dog prior to any experimental
maneuver.
GFR autoregulation was determined by computing
the product of renal inulin exti action and renal plas-
ma flow (RPF) during each sequential reduction in
RPP. Following these baseline observations, RPP
was allowed to return to control levels by releasing
the constriction, and after a delay of 10 to 15 mm,
furosemide (Lasix®, Hoechst-Roussel Pharmaceuti-
cals, Inc.) was administered i.v. (5 mg/kg), followed
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by a maintenance infusion at 5 mg/kg/hr. As urine
flow began to increase, drug-induced volume con-
traction was minimized as urine losses were replaced
quantitatively with warm (370 C) isotonic saline
infused via a femoral vein. The autoregulatory capa-
bility of RBF and GFR were reexamined at two
timed intervals (15 and 60 mm) during this continu-
ous furosemide infusion.
In addition, before and during furosemide infusion
and prior to reducing RPP for autoregulation studies,
systemic and renal venous blood samples were
obtained and assayed for renin activity to compute
RSR.
Autoregulatory ability in the control period was
excellent; within 40 sec of each pressure change
above 60 mm Hg, RBF returned to control values.
Therefore, in monitoring RBF at various pressures, a
complete autoregulation curve could be determined
within six minutes. Thus, the relationship between
RPP and RBF at 15 and 60 mm after furosemide
infusion was examined beginning three minutes
before and completed approximately three minutes
after each time period mentioned above.
Due to the complex nature of inulin retention with-
in the tubular system when changes in RPP are
induced acutely (even with a high urine flow rate
achieved with furosemide), we felt that conventional
inulin clearance measurements would not accurately
estimate GFR. It was of interest, however, to exam-
ine the saliuretic effect of furosemide at various
times following diuretic administration. Thus, in six
dogs, a two-minute urine collection for analysis of
urine flow rate and fractional excretion of sodium
(FENa) was initiated shortly before the 15- and 60-mm
time periods at endogenous RPP. Midpoint collec-
tions of arterial and left renal venous blood permitted
GFR to be calculated by the product of inulin extrac-
tion and RPF during this short collection period. In
addition, the urine was analyzed for sodium concen-
trations in order to document the speed and efficien-
cy of the diuretic in effecting a stable FENa within the
first hour after its administration.
Effect of furosemide on RBF autoregulation dur-
ing the inhibition of PG synthesis (group 2, N = 10).
Dogs were prepared in an identical manner to those
in group 1. After RBF autoregulation was deter-
mined in the control period, however, dogs received
either indomethacin i.v. (10 mg/kg, N = 8) or RO 20-
5720 i.v. (2 mg/kg, N = 2) slowly over a five-mm
period. Both of these agents inhibit renal PG synthe-
sis [9, 101. Forty-five minutes after administration of
either indomethacin or RO 20-5720, RBF autoregula-
tory capability was reexamined. Then, at 60 mm,
furosemide was administered (5mg/kg, prime; and 5
mg/kg/hr), and RBF autoregulatory capability was
reexamined 15 mm after initiation of furosemide
infusion.
Analytical methods. Inulin concentration in plas-
ma and urine was measured using an autoanalyzer
(Technicon) [11]. Sodium was measured using a
flame photometer (Instrumentation Labs.). PRA was
determined in six dogs using the radioimmunoassay
as described by Haber et al [12]. Hematocrits (Hct)
were obtained by centrifugation of blood in micro-
hematocrit capillary tubes. Plasma furosemide con-
centrations were measured with a high pressure liq-
uid chromatography technique.
Calculations. RPF was calculated from the RBF
as determined by the electromagnetic flow meter and
the hematocrit according to the formula: RPF =
RBF x (1 — Hct). Inulin extraction data were used
for the estimation of GFR according to the formula
[1]: GFR = RPF x ((A10 — V1)/A10), where A1 and
V11. are arterial and renal venous inulin concentra-
tions. Thirty simultaneous estimates of GFR with
this method and the conventional method (U111/P1 x
V) gave virtually identical results with a coefficient of
variation of 4%. U1 and P10 are inulin concentrations
in urine and plasma, and V is the urine flow rate.
RVR was calculated from RPP/RBF and expressed
as mm Hg/mi. min g.
RSR (ng/min g of kidney wt) was determined from
the following formula: RSR = RPF x (VPRA — APRA),
where VPRA and APRA are the renal venous and arteri-
al plasma renin activities, respectively. At the end of
each experiment, the experimental kidney was
removed, decapsulated, blotted dry, and weighed in
order to express RBF and GFR in terms of mlImin g
of kidney.
Data was analyzed using analysis of variance
(Duncan's multiple comparison's test) and the Stu-
dent's t test for paired data. Equations of regression
lines were determined using the method of least
squares. A P value of < 0.05 was considered signifi-
cant. Data are expressed as mean SEM.
Results
Group 1: RBF and GFR autoregulation during
furosemide alone. Table 1 summarizes the renal
hemodynamic studies before and during furosemide
infusion in ten dogs. During the control period, RBF
autoregulatory capability was excellent, as RBF
remained relatively constant at approximately 3.9
mlImin g during each 20-mm Hg reduction in RPP
from 140 to 80 mm Hg. Below 80 mm Hg, REF
decreased with further reduction in RPP averaging
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Table 1. Renal blood flow (RB F) autoregulation before and during furosemide administrationa
3.06 0.45 and 1.69 0.36 mllmin•g at pressures of
60 and 40 mm Hg, respectively. Over the RPP range
examined in this study, RVR fell in a progressive
manner from 37 5 at 140 mm Hg to 22 3 mmHgl
ml min• g at 80 mm Hg. Below 80 mmHg, RVR
tended to remain constant (Table 1).
Fifteen minutes after furosemide administration,
RBF had increased substantially; in addition, auto-
regulation of RBF was found to be abolished (Table
1). At RPP of 140 and 120 mm Hg, RBF was signifi-
cantly (P <0.01) elevated above control, 6.10 0.75
and 5.20 0.61 mllmin g, respectively. At this time,
RVR at 140 and 120 mm Hg was reduced 39% and
29% below control, respectively. At RPP of 100, 80,
60, and 40 mmHg, however, RBF was not signifi-
cantly different during furosemide compared to RBF
at these same pressures prior to furosemide. Statisti-
cal analysis of the data indicated that RBF at each
RPP was significantly different from each other 15
mm after furosemide (Table 1).
After maximum RBF had been demonstrated at 15
mm, RBF began to decrease. By 30 mm, a decrease
in RBF, more noticeable at the higher RPP, was
clearly demonstrable. This decrease gradually con-
tinued until 60 mm.
At 60 mm RBF and autoregulatory capability both
returned to control. RBF which averaged 3.89 0.52
mIIming at a RPP of 140 mm Hg was essentially
unchanged with reductions in RPP to 80 mm Hg
(Table 1). RVR averaged 37 5 and 19 2 mm Hg!
ml min g at a RPP of 140 and 80 mmHg, values
almost identical to those observed prior to furosem-
ide. The overall relationship between RPP and RBF
prior to and at 15 and 60 mm during furosemide
infusion is summarized in Figure 1. These data sug-
gest that there is abolition of RBF autoregulation at
15 mm and autoregulation is reestablished by 60 mm.
Figure 2 demonstrates the relationship between
RPP and GFR prior to and 15 mm after furosemide
infusion. During the pre-drug administration period,
GFR averaged 0.54 0.05 ml/min•g and autoregulat-
ed well to RPP as low as 80 mm Hg. GFR autoregula-
Renal perfusion pressure, mm Hg
140±4 120±2 100±3 80±1 60±2 40±1
Control
RBF, mllming 3.96 3.96 3.94 3.88 3,06d 169d
RVR5, mm Hg/mIming 37 35d 27' 22d 22 23
Furosemide, 15 mm
RBF 6.10' 520c.d 432 354d 2.6l 2.0l'
RVRb 23C 23C 23 24 21 23
Furosemide, 60 mm
RBF 3.89 3.89 4.13 3.59 314d 228d
RVR5 37 32d 25d 19d 18 17
Values are mean SEM in ten dogs.
b RVR = renal vascular resistance.
P < 0.01 (Student's paired t test vs. control).
P <0.05 (analysis of variance, Duncan's multiple comparison
6.0
.——. C
A—-—A F + 15 miii
60 mm
/
3.0 i
2.0
test), compared to preceding (higher) renal perfusion pressure.
5,
0
0
U-
m
0 160
Fig. 1. Relationship between renal perfusion pressure and renal
blood flow (RBF) during control (solid circle) and during furosem-
ide infusion at 15 mm (solid triangle) and at 60 mm (open circle).
The equation of the line described IS mm after furosemide admin-
istration is y = 0.04X + 0.23 (r = 0.66, P < 0.01).
1.0
20 40 60 80 100 120 140
Renal perfusion pressure, mm Hg
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tion was still present at the 15-mm period and aver-
aged 0.49 0.06 mllmin•g. Despite the rise in RBF,
a slight but insignificant decrease in mean GFR was
observed. In addition, at 60 mm, GFR autoregulation
was still present, averaging 0.57 0.03 ml/min g at
both 140 and 80 mm Hg.
RSR, expressed as ngImin g, was measured in six
dogs prior to and during furosemide infusion (Table
2). During the control period, RSR averaged 7.8
3.9 ng!min.g at a RPP of 122 4; at 15 mm, RSR
increased significantly (P < 0.01) to 14.6 1.6 ng/
ming. By 60 mm, RSR had returned to control
values of 6.5 1.8 ng/min.g. Thus, RSR was most
elevated at the time when RBF was also highest. At
RPP of 122 4 mm Hg, FENa averaged 18.2 0.9%
at 15 mm and was unchanged at 60 mm, averaging
20.3 2.7% even in the presence of a constant GFR
and a much different RBF (Table 2).
Group 2: RBF and GFR autoregulation during
furosemide in the presence of PG inhibition. In a
Control 7.8 0.9 122 3.9
3.9 4
Furosemide, +15 mm
Furosemide, +60 mm
14.6c
1.6
6.5
1.8
18.2c
20.3c
116
111
7
5.IJ
39
o Control
• Furosemide, + 15 mm
separate series of animals, the effect of furosemide
on RBF autoregulation was reexamined during inhi-
bition of PG synthesis. These results are summarized
in Table 3 and Figure 3. Autoregulation of RBF was
clearly present during the control period; RBF was
relatively unchanged during RPP reduction, averag-
ing 3.88 0.2 at 140mm Hg and 3.54 0.2 mlImin g
at 80 mm Hg (P < 0.05). Below 80 mm Hg, RBF
decreased in proportion to decreased RPP. Within
the autoregulatory range (140 to 80 mm Hg), RVR
decreased from 37 2 to 23 1 mm Hg/mlming.
Forty-five minutes after the administration of
either indomethacin or RO 20-5720, a significant
reduction in RBF, at all RPP's studied, was observed
(eg., 3.88 0.23 vs. 2.59 0.24 mllming, P < 0.01,
at 140 mm Hg). RVR rose significantly from control
at all RPP's during this period of PG synthesis inhibi-
tion (eg., 37 2 vs. 58 5 mm Hg/ml.min.g, 1 <
0.01, at 140 mm Hg). The kidney, however, still
retained the ability to autoregulate RBF when RPP
was reduced from 140 to 80 mm Hg.
Fifteen minutes after initiating furosemide infu-
sion, in this setting of reduced PG synthesis, RBF
increased significantly from 2.59 0.24 to 4.05 0.5
and 3.56 0.4 ml/min•g at RPP of 140 and 120 mm
Hg, respectively. Figure 3 clearly demonstrates that
RBF during furosemide infusion changed in direct
proportion to changes in RPP. In addition, there
were significant differences between each RBF at
each RPP (Table 3). At 15 minutes and at RPP's of
100, 80, 60, and 40 mm Hg, however, RBF was
similar during furosemide infusion to that observed
during PG inhibition alone. RVR, after furosemide
administration, reached its nadir and remained
unchanged throughout the entire range of RPP
examined.
Discussion
In the present investigation, we have examined
renal hemodynamic responses to furosemide [13]
when ECF volume is maintained [14], and we con-
firm that at modestly elevated RPP, RBF does
increase shortly after administration of the diuretic;
within one hour, however, RBF returns to control,
although the saliuretic effect is not diminished. The
earliest measurements of RBF in the present study
were conducted 15 mm after administration. When
RPP was 120 mm Hg or higher, significant increases
in RBF were observed; higher pressures were associ-
ated with even higher RBF. This vasodilatation,
however, was not sustained, and by 60 mm RBF was
similar to control at all pressures examined.
The magnitude of the early rise in RBF was exam-
ined more closely by determining the pressure (RPP)
Table 2. Renin secretory rate (RSR) and fractional sodium
excretion (FENd) before and during furosemide administrationab
RSR FEN. RPP RBF
nglmin g % mm Hg mi/mm g
Values are mean SEM in six dogs.
b Other abbreviations used are: RPP, renal perfusion pressure;
RBF, renal blood flow.
P < 0.05, compared to control.
1.Or
0
U-
0.5
60 80 100 120 140
Renal perfusion pressure, mm Hg
Fig. 2. Relationship between renal pe,'jlisionpressure and glomer-
u/ar filtration rate (GFR) during control (open circle) and during
furosemide at 15 mm (closed circle). The same relationship was
present at 60 mm (not shown).
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Table 3. Renal blood flow (RBF) autoregulation before and during prostaglandin inhibition without and with furosemide at 15 mm
Renal perfusion pressure, mm Hg
140±2 120±2 100±2 80±! 60±2 40±1
Control
RBF 3.88 3.88 3.88 3.54 3.04e 1.96
RVRa 37 32C 27C 23C 21 23
Inhibitor (I)
RBF 2.59k 259b 251k 2.36k 2025,c 13Jh.C
RVR 58 50h, 445.C 40b.c 39b 375
I + furosemide
RBF 405d 3.56c 3.03e 2.52w l.89' l.38
RVR5 39d 38d 38 37 38 39
a RVR, renal vascular resistance.
P < 0.01 (paired t test vs. control).
P <0.05 (analysis of variance, Duncan's multiple comparison test), compared to preceding (higher) renal perfusion pressure.
ci P <0.01 (paired (test vs. I).
0
________0 20 40 60 80 100 120 140
Renal perfusion pressure, mm Hg
Fig. 3. Relationship between renal perfusion pressure and renal
blood flow (RBF) during control (solid circle), 45 mm after admin-
istration of either indomethacin or RO 20-5720 (closed triangle),
and 15 mm after furosemide administration (open circle). The
equation of the line described 15 nun after initiation of furosemide
is y = 0.02X + 0.31 (r 0.63, P < 0.01).
to flow (RBF) relationship in the left kidney of each
dog prior to and during furosemide administration.
This baseline determination of RBF autoregulatory
capability in each dog appeared to be an appropriate
control for the diuretic studies on renal hemodynam-
ics, because if a kidney preparation did not exhibit
good renal autoregulatory capability during the con-
trol period (that is, the ability of renal vasculature to
vasodilate and maintain RBF in response to
decreased RPP), then the vasculature may not have
responded to furosemide administration during the
experimental period. All animals used in these stud-
ies exhibited good autoregulation during the control
period. The pressure-flow relationship was usually
examined at two to three additional pressures below
the point of minimal RVR. Within 15 mi furosem-
ide increased RBF to 6.1 mllming at a RPP of 140
mm Hg. This increase is about 56% above control
(3.9 mlJmin g). When RPP was acutely reduced to
120 mm Hg, RBF was lower, averaging 5.2 ml!
mm g. At approximately 100 mm Hg, however, little
increase in RBF was noted. In addition, there were
significant differences in RBF 15 mm after furosem-
ide infusion between each RPP examined. These
observations may also explain, in part, why some
investigators [15, 16] using similar doses of furosem-
ide have reported either much smaller (8%) or equiv-
alent (48%) increases in RBF in dogs. Close attention
to the level of RPP (and the time after administration)
at which vasodilatation is measured appears to be
necessary in evaluating the magnitude of renal vaso-
dilatation following diuretic administration.
The present results also demonstrate that GFR
was autoregulated during the control period and at 15
and 60 mm during furosemide infusion. The slight but
insignificant decrease in mean GFR observed at 15
mm may have been due to an increasing intratubular
pressure associated with diuretic administration
[17]. The constancy of GFR at all RPP at 15 mm in
the presence of a simultaneous pressure-related
increase in RBF is a response similar to and charac-
teristic of the renal responses to other vasodilators,
such as acetyicholine [1].
Acute changes in RBF have been shown to alter
Starling forces in the post-glomerular peritubular
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capillary circulation and, thus, may lead to changes
in proximal nephron reabsorption [811. Therefore, the
present study suggests that with rapidly changing
renal hemodynamics within the first hour after furo-
semide infusion, disagreements concerning the
effects of furosemide on the inhibition of proximal
nephron fluid transport may be due, in part, to time
and the level of RPP at which reabsorption is reex-
amined [14, 19—21].
In the present studies, we have attempted to
explore the mechanism by which furosemide could
inhibit RBF autoregulation early after its administra-
tion, but not at 60 mm. Neither changes in ECF
volume nor changing plasma concentrations of furo-
semide would appear to be the factors involved,
since urine losses were carefully replaced, and a
continuous furosemide infusion was maintained.
Plasma furosemide concentrations averaged 22 1
and 18 2 pg/ml at 15 and 60 mm (P > 0.05),
respectively. In addition, the natriuresis developed
at 15 mm was no different than that observed at 60
mm. We considered the role of a potential intrarenal
vasodilator, the PG system. lit is known that furo-
semide is a potent stimulus for renin release from the
kidney [22] and increased concentrations of angio-
tensin II can stimulate renal PG-E2 secretion [23]. In
the present study, RSR was clearly increased at 15
mm following furosemide infusion (Table 2). Fur-
thermore, Williamson et al [8] have shown that furo-
semide can quickly elevate PG-E2 levels in the renal
venous blood. In addition, intrarenal infusions of
PG-E2 can depress RBF autoregulatory capability,
while GFR autoregulation is well maintained [1].
Therefore, in another series of experiments, we rein-
vestigated the effect of furosemide administration on
RBF autoregulation in the absence of PG, by pre-
treating animals with agents which inhibit PG synthe-
sis [24]. In all experiments, we observed a consistent
fall in RBF during the 45 mm following the adminis-
tration of either indomethacin or RO 20-5720; this
agrees with the findings of others [25, 26]. Neverthe-
less, despite the lack of PG, RBF autoregulatory
capability was still intact, although it was reset to a
new level as both RBF and RVR were altered from
control values. The maintenance of RBF autoregula-
tion following administration of PG inhibitors con-
firms previous reports of acute studies in both the rat
[27] and dog [28] and in chronic studies in the dog
[29].
Administration of furosemide, in the setting of
reduced PG concentrations, was accompanied by a
significant increase in RBF at RPP of 140 and 120
mm Hg. This ability of furosemide to increase RBF,
despite PG inhibition, appears to be in conflict with
recent reports [16, 30]. In both those studies, how-
ever, RPP was not reported, and a continuous infu-
sion of furosemide was not given. Our studies clearly
indicate that the furosemide-induced increase in
RBF is, in part, determined by RPP and suggest that
if the present studies had taken place at a RPP of
about 100mm Hg, then no signficant increase in RBF
would have been observed. Nevertheless, an even
greater increase in RBF could be observed 15 mm
after furosemide administration at RPP of 140 and
120 mm Hg when PG's were present (i.e., when
indomethacin or RO 20-5720 had not been used to
block PG synthesis). These results suggest that PG's
are necessary for normal maintenance of RBF, but
they do not appear to mediate the increase in RBF
following furosemide administration nor are they
necessary for RBF autoregulation in the anesthetized
dog.
A potential explanation for the impairment of RBF
autoregulation with infusions of furosemide, which
has not been explored in the dog, may be due to a
desensitization of the macula densa area of the distal
nephron. Furosemide reaches this distal nephron site
both by glomerular filtration and proximal secretion
[31]. Wright and Schnermann [321 have demonstrat-
ed that distal nephron perfusion with Ringer's solu-
tion containing 10 M furosemide is capable of inhib-
iting a tubuloglomerular (TG) feedback response to
increased distal perfusion rate. In the present study,
furosemide may have similarly inhibited a TG feed-
back system; however, the return of the renal sys-
tem' s autoregulatory ability with time and with con-
tinuous furosemide infusion suggests that the macula
densa TG feedback system may recover from any
desensitization rather quickly.
In summary, results of the present investigation
have demonstrated that renal vasodilatation which
accompanies furosemide administration is dependent
upon the level of RPP and also is an early event, the
effect of which wanes with time. Afferent arteriolar
vascular responsiveness to changes in RPP was abol-
ished, and RVR fell to a minimum. Although the
mechanism for this furosemide-induced loss of RBF
autoregulation is not known, we feel that at least the
renal PG system does not mediate this response. The
present data suggest that when examining some
aspects of renal hemodynamic or tubular function
following furosemide infusion, time after administra-
tion and RPP are important variables which should
be considered, since changes in RBF appear to be
related to both of these variables.
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